A detailed history of Heritage Wealth Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Heritage Wealth Advisors holds 9,428 shares of ABBV stock, worth $1.7 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
9,428
Previous 8,345 12.98%
Holding current value
$1.7 Million
Previous $1.43 Million 30.05%
% of portfolio
0.09%
Previous 0.07%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $177,438 - $215,874
1,083 Added 12.98%
9,428 $1.86 Million
Q2 2024

Dec 12, 2024

SELL
$154.79 - $180.76 $138,846 - $162,141
-897 Reduced 9.71%
8,345 $1.43 Million
Q2 2024

Aug 05, 2024

SELL
$154.79 - $180.76 $138,846 - $162,141
-897 Reduced 9.71%
8,345 $1.43 Million
Q1 2024

Dec 12, 2024

SELL
$159.82 - $182.1 $19,657 - $22,398
-123 Reduced 1.31%
9,242 $1.68 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $42,032 - $47,892
-263 Reduced 2.77%
9,242 $1.68 Million
Q4 2023

Dec 12, 2024

BUY
$137.6 - $154.97 $59,305 - $66,792
431 Added 4.82%
9,365 $1.45 Million
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $78,569 - $88,487
571 Added 6.39%
9,505 $1.47 Million
Q3 2023

Dec 12, 2024

SELL
$133.59 - $154.65 $140,269 - $162,382
-1,050 Reduced 10.52%
8,934 $1.33 Million
Q3 2023

Nov 08, 2023

SELL
$133.59 - $154.65 $140,269 - $162,382
-1,050 Reduced 10.52%
8,934 $1.33 Million
Q2 2023

Dec 12, 2024

BUY
$132.51 - $164.9 $73,675 - $91,684
556 Added 5.9%
9,984 $1.35 Million
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $2,650 - $3,298
-20 Reduced 0.2%
9,984 $1.35 Million
Q1 2023

May 04, 2023

BUY
$144.61 - $166.54 $23,860 - $27,479
165 Added 1.68%
10,004 $1.59 Million
Q4 2022

Dec 12, 2024

BUY
$138.31 - $165.87 $52,557 - $63,030
380 Added 4.02%
9,839 $1.59 Million
Q4 2022

Feb 06, 2023

BUY
$138.31 - $165.87 $52,557 - $63,030
380 Added 4.02%
9,839 $1.59 Million
Q3 2022

Dec 12, 2024

BUY
$134.21 - $153.93 $4,160 - $4,771
31 Added 0.33%
9,459 $1.27 Million
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $155,683 - $178,558
1,160 Added 13.98%
9,459 $1.27 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $182,208 - $231,647
1,324 Added 18.98%
8,299 $1.27 Million
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $923 - $1,146
7 Added 0.1%
6,975 $1.13 Million
Q4 2021

Feb 02, 2022

BUY
$107.43 - $135.93 $64,243 - $81,286
598 Added 9.39%
6,968 $943,000
Q3 2021

Nov 02, 2021

BUY
$106.4 - $120.78 $41,176 - $46,741
387 Added 6.47%
6,370 $687,000
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $146,767 - $163,507
1,395 Added 30.41%
5,983 $673,000
Q2 2021

Jul 27, 2021

SELL
$105.21 - $117.21 $32,615 - $36,335
-310 Reduced 6.33%
4,588 $492,000
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $31,713 - $34,912
310 Added 6.76%
4,898 $530,000
Q4 2020

Feb 01, 2021

BUY
$80.49 - $108.67 $1,046 - $1,412
13 Added 0.28%
4,588 $492,000
Q2 2020

Jul 17, 2020

SELL
$73.37 - $98.18 $156,278 - $209,123
-2,130 Reduced 31.77%
4,575 $449,000
Q2 2020

Jul 17, 2020

BUY
$73.37 - $98.18 $130,085 - $174,073
1,773 Added 35.95%
6,705 $449,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $20,640 - $31,292
320 Added 6.94%
4,932 $375,000
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $2,668 - $3,339
37 Added 0.81%
4,612 $408,000
Q3 2019

Oct 30, 2019

SELL
$62.98 - $75.72 $9,950 - $11,963
-158 Reduced 3.34%
4,575 $346,000
Q2 2019

Aug 05, 2019

BUY
$65.7 - $83.98 $22,600 - $28,889
344 Added 7.84%
4,733 $0
Q1 2019

May 06, 2019

BUY
$77.14 - $90.79 $27,847 - $32,775
361 Added 8.96%
4,389 $0
Q4 2018

Jan 28, 2019

SELL
$77.85 - $96.01 $13,779 - $16,993
-177 Reduced 4.21%
4,028 $371,000
Q2 2018

Jul 19, 2018

SELL
$89.78 - $106.23 $4,578 - $5,417
-51 Reduced 1.2%
4,205 $389,000
Q1 2018

May 10, 2018

SELL
$92.01 - $123.21 $13,065 - $17,495
-142 Reduced 3.23%
4,256 $404,000
Q4 2017

Feb 02, 2018

SELL
$89.56 - $98.21 $20,688 - $22,686
-231 Reduced 4.99%
4,398 $425,000
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $323,335 - $412,999
4,629
4,629 $411,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.